
09/04/2025
The has asked Outlook Therapeutics to provide additional data supporting its BLA for ONS-5010 (ophthalmic bevacizumab). Read more: https://ow.ly/mMs250WPUWt
Therapeutic and Surgical Treatment of the Posterior Segment
321 Norristown Road
Ambler, PA
19382
Be the first to know and let us send you an email when Retinal Physician posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Retinal Physician: